China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. clinical trials

A subsidiary of China Resources Pharmaceutical Group Limited

The registry lists 5 studies whose lead sponsor is China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Feb 21, 2022.

Status

Status unknown: 4
Completed: 1

Phase

Phase 4: 3
Phase 2: 1

Where

China: 3

Registry sponsor names on this page

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.5 studies

Something wrong with this grouping? Tell us on the China Resources Pharmaceutical Group Limited page.

Studies

Recruiting first, then most recently updated. Showing 5 of 5. All China Resources Pharmaceutical Group Limited studies →

A Real World Study of the Treatment of Gastric Adenocarcinoma With HuachansuStatus unknownNCT05249244
Sponsor listed in the registry: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
Exploratory Study on Dosage of Qizhi Weitong Granules in the Treatment of Irritable Bowel Syndrome （IBS)Status unknownNCT05113888Phase 2
Sponsor listed in the registry: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
Jinfukang Oral Liquid Combined With Chemotherapy for Treating Driver Gene-negative Advanced NSCLCStatus unknownNCT05098990Phase 4
Sponsor listed in the registry: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
Efficacy and Safety of Yuxuebi Tablet in Treating Night Pain of Ankylosing Spondylitis (AS).Status unknownNCT04934059Phase 4
Sponsor listed in the registry: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
A Study to Evaluate the Efficacy and Safety of Shenfu Zhusheye in Patients With Acute Heart FailureCompletedNCT02135835Phase 4
Sponsor listed in the registry: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.